IE
UPC icon

Israel Englander’s Universe Pharmaceuticals Inc UPC Stock Holding History

Israel Englander’s Portfolio UPC Stock Details UPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23
Closed -$3.37K – 6475
2024
Q3 		$3.37K Buy
+23
New +$39.1K ﹤0.01% 5947
2021
Q2 		– Sell
-9
Closed -$128K – 7133
2021
Q1 		$128K Buy
+9
New +$144K ﹤0.01% 5639

Other funds holding UPC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's UPC Position: Q4 2024 in Review

Israel Englander sold out of Universe Pharmaceuticals Inc (UPC) in Q4 2024, closing a stake of 23 shares — an estimated $3.37K sold.

Israel Englander first reported a position in UPC in Q1 2021 and held it in 2 quarters. The position peaked at $128K in Q1 2021. 3 funds tracked by Wall St. Rank hold UPC as of Q4 2024.

  • Israel Englander reported no remaining Universe Pharmaceuticals Inc position as of Q4 2024 after selling out during the quarter.
  • Israel Englander sold 23 Universe Pharmaceuticals Inc shares in Q4 2024, an estimated $3.37K.
  • Israel Englander first reported a position in Universe Pharmaceuticals Inc in Q1 2021 and held it in 2 quarters.
  • Israel Englander's Universe Pharmaceuticals Inc position peaked at $128K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.